{"id": "1376108977059205127", "creation": 1616924921.0, "user_id": "88902818", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "#China National Pharmaceutical Group (Sinopharm) will need to assess results from overseas Phase III clinical trials to decide whether its two-shot COVID-19 #vaccine should be followed by a booster shot, a company executive said.\n\n#COVID19 \n\nRead more: https://t.co/Ou3385r9nX", "first_save": 1634559108.199414, "hashtags": ["#CHINA", "#VACCINE", "#COVID19"]}